Ortner, G.; Mavridis, C.; Fritz, V.; Schachtner, J.; Mamoulakis, C.; Nagele, U.; Tokas, T.
The Added Value of MRI-Based Targeted Biopsy in Biopsy-Naïve Patients: A Propensity-Score Matched Comparison. J. Clin. Med. 2024, 13, 1355.
https://doi.org/10.3390/jcm13051355
AMA Style
Ortner G, Mavridis C, Fritz V, Schachtner J, Mamoulakis C, Nagele U, Tokas T.
The Added Value of MRI-Based Targeted Biopsy in Biopsy-Naïve Patients: A Propensity-Score Matched Comparison. Journal of Clinical Medicine. 2024; 13(5):1355.
https://doi.org/10.3390/jcm13051355
Chicago/Turabian Style
Ortner, Gernot, Charalampos Mavridis, Veronika Fritz, Jörg Schachtner, Charalampos Mamoulakis, Udo Nagele, and Theodoros Tokas.
2024. "The Added Value of MRI-Based Targeted Biopsy in Biopsy-Naïve Patients: A Propensity-Score Matched Comparison" Journal of Clinical Medicine 13, no. 5: 1355.
https://doi.org/10.3390/jcm13051355
APA Style
Ortner, G., Mavridis, C., Fritz, V., Schachtner, J., Mamoulakis, C., Nagele, U., & Tokas, T.
(2024). The Added Value of MRI-Based Targeted Biopsy in Biopsy-Naïve Patients: A Propensity-Score Matched Comparison. Journal of Clinical Medicine, 13(5), 1355.
https://doi.org/10.3390/jcm13051355